Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 3Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 1Gastrointestinal 1

Conditions

Other Cancer 1Neoplasms 1Gastrointestinal Neoplasms 1

Interventions

Cyclophosphamide 1492Cisplatin 1414Paclitaxel 1317Radiotherapy 1261Carboplatin 1250Gemcitabine 1215Docetaxel 1109Bevacizumab 1030Fluorouracil 894Doxorubicin 792Dexamethasone 748Rituximab 719Capecitabine 716Oxaliplatin 700pembrolizumab 680Etoposide 678Irinotecan 634Filgrastim 621Cytarabine 586Leucovorin 579Nivolumab 558Vincristine 515Prednisone 475Cetuximab 465Bortezomib 459Erlotinib Hydrochloride 456Trastuzumab 447Methotrexate 438Lenalidomide 427Pemetrexed 420

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Interventional × Advance Care Planning × Clear all
NCT03609177 2025-10-21

ACP-PEACE

Dana-Farber Cancer Institute

Phase NA Completed
13,800 enrolled 15 charts

Other Cancer

NCT03676426 2020-05-07

Comparison of a Web-based Advance Directive to a Standard Advance Directive

University of Pennsylvania

Phase NA Completed
90 enrolled
Gastrointestinal

Gastrointestinal Neoplasms

NCT01670461 2019-03-08

FACE

Children's National Research Institute

Phase NA Completed
60 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡